InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,555.74
(
-0.16%
)
US TECH 100
19,107.20
(
-0.96%
)
Dow Jones
40,358.09
(
-0.14%
)
Brent Oil
80.64
(
-0.17%
)
Bitcoin
65,938.57
(
0.05%
)
Post# of 43124
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Knuckle Sandwich

Send PM Follow Ignore
Followers 16
Posts 1561
Boards Moderated 0
Alias Born 02/27/2014

Knuckle Sandwich

Re: archefal post# 31890

Sunday, 08/08/2021 12:13:09 AM

Sunday, August 08, 2021 12:13:09 AM

Post# of 43124
I am guessing as well here, but I assume they are fully enrolled since they had similar trail dates as the Lenz Arm. Lenz had an interim readout, and the trial was expanded following positive results with NIH and I'm not sure about ACTIV-5 A Risankizumab but think that trial not showing expanded is pretty telling.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up